BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9113934)

  • 21. A case of blastic NK-cell lymphoma.
    Akasaka E; Mabuchi T; Umezawa Y; Iwashita K; Ohta Y; Matsuyama T; Ozawa A
    Int J Dermatol; 2007 Jul; 46(7):722-6. PubMed ID: 17614802
    [No Abstract]   [Full Text] [Related]  

  • 22. Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B.
    Todeschini G; Secchi S; Morra E; Vitolo U; Orlandi E; Pasini F; Gallo E; Ambrosetti A; Tecchio C; Tarella C; Gabbas A; Gallamini A; Gargantini L; Pizzuti M; Fioritoni G; Gottin L; Rossi G; Lazzarino M; Menestrina F; Paulli M; Palestro M; Cabras MG; Di Vito F; Pizzolo G
    Br J Cancer; 2004 Jan; 90(2):372-6. PubMed ID: 14735179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Precursor B-cell lymphoblastic lymphoma involving the skin.
    Kim JY; Kim YC; Lee ES
    J Cutan Pathol; 2006 Sep; 33(9):649-53. PubMed ID: 16965342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Malignant non-Hodgkin diffuse lymphoma with extranodal orbital involvement--a clinical case].
    Epure C; Ionascu L; Hagima N; Nan S; Stefaniu I
    Oftalmologia; 2005; 49(4):29-32. PubMed ID: 16524121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Relapse of diffuse large B cell lymphoma to CD20-negative multiple cutaneous tumors immediately after anti-CD20 monoclonal antibody (rituximab) therapy].
    Iguchi T; Miyazawa K; Okabe S; Kawakubo K; Shimamoto T; Kuriyama Y; Ito Y; Kimura Y; Ohyashiki K; Serizawa H; Iwaya K; Mukai K
    Rinsho Ketsueki; 2004 Oct; 45(10):1129-34. PubMed ID: 15553050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutaneous intravascular lymphoma following extravascular lymphoma of the lung.
    Tomasini C; Novelli M; Ponti R; Pippione M; Bernengo MG
    Dermatology; 2004; 208(2):158-63. PubMed ID: 15057009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Non-Hodgkin malignant lymphoma of rib origin: report of a case].
    Kambayashi T; Ono N; Terada Y
    Kyobu Geka; 2005 Dec; 58(13):1177-80. PubMed ID: 16359022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary non-Hodgkin's lymphoma of the mandible. Report of a case.
    Longo F; De Maria G; Esposito P; Califano L
    Int J Oral Maxillofac Surg; 2004 Dec; 33(8):801-3. PubMed ID: 15556331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary non-Hodgkin's lymphoma of the jaws: Report of 4 cases and review of the literature.
    Pazoki A; Jansisyanont P; Ord RA
    J Oral Maxillofac Surg; 2003 Jan; 61(1):112-7. PubMed ID: 12524617
    [No Abstract]   [Full Text] [Related]  

  • 30. [Malignant lymphoma].
    Mori T
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):162-6. PubMed ID: 17301521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Skin infiltration in malignant lymphoma].
    Hengstler P
    Praxis (Bern 1994); 1998 May; 87(20):705-6. PubMed ID: 9633230
    [No Abstract]   [Full Text] [Related]  

  • 32. Cytomorphology of a case of primary cutaneous B-cell lymphoma.
    Jain M; Agarwal K; Langer S; Aggarwal M
    Indian J Pathol Microbiol; 2007 Oct; 50(4):877-80. PubMed ID: 18306596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Homogeneous clinical behavior of a group of cutaneous B-cell lymphomas].
    de Misa RF; Sastre JL; Azaña JM; Escribano L; Suárez J; Bellas C
    Sangre (Barc); 1995 Dec; 40(6):465-70. PubMed ID: 8850229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis.
    Ghesquières H; Berger F; Felman P; Callet-Bauchu E; Bryon PA; Traverse-Glehen A; Thieblemont C; Baseggio L; Michallet AS; Coiffier B; Salles G
    J Clin Oncol; 2006 Nov; 24(33):5234-41. PubMed ID: 17043351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Beneficial effects of CHOP therapy in a case of intravascular large B-cell lymphoma diagnosed by skin biopsy].
    Munakata S; Hirano S; Yoshiyama Y; Koizumi M; Kobayasi T; Hattori T
    Rinsho Shinkeigaku; 2000 May; 40(5):476-9. PubMed ID: 11002731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravascular large B-cell lymphoma of the skin: typical clinical manifestations and a favourable response to rituximab-containing therapy.
    Feldmann R; Schierl M; Sittenthaler M; Jahn R; Wogritsch C; Cerroni L; Steiner A; Breier F
    Dermatology; 2009; 219(4):344-6. PubMed ID: 19590171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cutaneous plasmablastic lymphoma.
    Jambusaria A; Shafer D; Wu H; Al-Saleem T; Perlis C
    J Am Acad Dermatol; 2008 Apr; 58(4):676-8. PubMed ID: 18342714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Low-grade cutaneous B-cell lymphoma: Failure of intralesional rituximab (Mabthera)].
    Abasq C; Duval-Modeste AB; Courville P; Joly P
    Ann Dermatol Venereol; 2008; 135(6-7):509-11. PubMed ID: 18598807
    [No Abstract]   [Full Text] [Related]  

  • 39. [Infiltration into the aqueous humor (uveitis) in a patient with malignant lymphoma].
    Hanamura A; Maeda H; Kuwayama W; Takano Y
    Rinsho Ketsueki; 1992 Dec; 33(12):1845-50. PubMed ID: 1479697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complete remission of a primary cutaneous B-cell lymphoma of the lower leg by first-line monotherapy with the CD20-antibody rituximab.
    Bonnekoh B; Schulz M; Franke I; Gollnick H
    J Cancer Res Clin Oncol; 2002 Mar; 128(3):161-6. PubMed ID: 11935303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.